FDA approves new type of non-opioid pain medication

By The Hill | Created at 2025-01-31 03:01:15 | Updated at 2025-01-31 05:57:50 3 hours ago

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and Research said in a statement. “A…

Read Entire Article